Business Management in the Cardiac Cath Labor...

Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phospholipids and lipoprotein(a). They discuss the potential mechanisms linking lipoprotein(a) to cardiovascular risk and how ongoing phase 3 re ...  Show more

In this excerpt from Tall Rounds®, Gianluca Torregrossa, MD, discusses minimally invasive and totally endoscopic coronary artery bypass grafting (TECAB), highlighting procedural advances that enable multi-vessel revascularization through less invasive approaches. Looking to refer ...  Show more

Obstructive hypertrophic cardiomyopathy therapy and septal reduction therapy via alcohol septal ablation and surgical myectomy is discussed by interventional cardiologist Dr. Amar Krishnaswamy and surgical perspective from cardiothoracic surgeon Dr. Per Wierup. Amit joins Dr. Lau ...  Show more

Drs. Noah Rosenberg, Nick Palmeri, and Wendy Stead discuss cardiac device infection diagnosis and management from the cardiology/EP and ID perspective!Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com 

Drs Coats, Bozkurt, Metra, and Zieroth discuss important updates regarding the management of patients with heart failure.

Credit available for this activity expires: 11/22/2022
Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/vie ...

Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.